# NovaBay Pharmaceuticals Inc. (NBY)

Source: https://www.quantisnow.com/company/NBY
Generated: 2026-11-14T19:14:17.463Z

- Ticker: NBY
- Exchange: AMEX
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2007
- Website: novabay.com

## About

NovaBay Pharmaceuticals, Inc., a medical device company, develops products for the eye care markets in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx Clinical Reset, a gentle and soothing facial spray; and NeutroPhase and PhaseOne for the wound care market. It also offers KN95 Masks. The company sells its products through distribution partners, as well as offers Avenova and CelleRx Clinical Reset through online sales channels. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

## Latest NBY news and filings

- 2026-04-28 12:00 UTC [Leadership Update] [Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments](https://www.quantisnow.com/insight/aterian-inc-announces-definitive-agreement-for-the-sale-of-its-6517706)
- 2026-04-09 20:50 UTC [SEC Form 4] [SEC Form 4 filed by Zheng Yenyou](https://www.quantisnow.com/insight/sec-form-4-filed-by-zheng-yenyou-6495060)
- 2026-04-08 20:54 UTC [SEC Form 4] [SEC Form 4 filed by Law Tommy](https://www.quantisnow.com/insight/sec-form-4-filed-by-law-tommy-6493223)
- 2026-04-06 12:43 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-results-of-operations-6488843)
- 2026-04-03 01:44 UTC [SEC Form 4] [SEC Form 4 filed by Kazley Michael John](https://www.quantisnow.com/insight/sec-form-4-filed-by-kazley-michael-john-6486538)
- 2026-04-02 20:54 UTC [SEC Form 4] [SEC Form 4 filed by Sit Swan](https://www.quantisnow.com/insight/sec-form-4-filed-by-sit-swan-6485489)
- 2026-04-01 20:23 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-amendments-6482160)
- 2026-03-23 12:37 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-results-of-operations-6464460)
- 2026-03-23 12:30 UTC [Conference Announcement] [NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update](https://www.quantisnow.com/insight/novabay-pharmaceuticals-announces-name-change-to-stablecoin-development-corporation-reports-6464422)
- 2026-03-19 21:00 UTC [SEC Form 10-K] [SEC Form 10-K filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-novabay-pharmaceuticals-inc-6461977)
- 2026-03-12 21:19 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-amendments-to-articles-6445363)
- 2026-03-02 22:21 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-novabay-pharmaceuticals-inc-6422840)
- 2026-02-20 21:24 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-material-modification-to-6404931)
- 2026-02-12 02:48 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-6387957)
- 2026-02-10 02:14 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-novabay-pharmaceuticals-inc-6382790)
- 2026-01-30 22:09 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Other Events](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-changes-in-registrants-6368368)
- 2026-01-30 22:03 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-novabay-pharmaceuticals-inc-6368340)
- 2026-01-30 00:30 UTC [SEC Form 4] [Large owner Lazar David E. was granted 6,388,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-lazar-david-e-was-granted-6388000-shares-sec-6366651)
- 2026-01-28 21:10 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-changes-in-registrants-6364041)
- 2026-01-27 17:43 UTC [SEC Form D] [SEC Form D filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-novabay-pharmaceuticals-inc-6361990)
- 2026-01-20 13:16 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-6353378)
- 2026-01-20 13:16 UTC [SEC Form 424B5] [SEC Form 424B5 filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-novabay-pharmaceuticals-inc-6353374)
- 2026-01-16 22:27 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-6352615)
- 2025-11-28 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-novabay-pharmaceuticals-inc-6295918)
- 2025-11-25 22:26 UTC [SEC Form S-8] [SEC Form S-8 filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-novabay-pharmaceuticals-inc-6294043)
- 2025-11-25 22:24 UTC [SEC Form S-3] [Amendment: SEC Form S-3/A filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-novabay-pharmaceuticals-inc-6294034)
- 2025-11-07 21:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by NovaBay Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-novabay-pharmaceuticals-inc-6268055)
- 2025-11-04 02:39 UTC [SEC Form 4] [Large owner Framework Ventures Iv L.P. converted options into 56,806,080 shares (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-framework-ventures-iv-lp-converted-options-into-56806080-6257486)
- 2025-11-04 02:38 UTC [SEC Form 4] [Large owner R01 Fund Lp converted options into 56,806,080 shares (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-r01-fund-lp-converted-options-into-56806080-shares-6257485)
- 2025-11-04 02:38 UTC [SEC Form 4] [Chief Executive Officer Kazley Michael John converted options into 56,806,080 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-kazley-michael-john-converted-options-into-56806080-6257484)
- 2025-10-23 01:27 UTC [SEC Form 4] [Amendment: SEC Form 4 filed by Large owner Framework Ventures Iv L.P.](https://www.quantisnow.com/insight/amendment-sec-form-4-filed-by-large-owner-framework-ventures-6242266)
- 2025-10-23 01:22 UTC [SEC Form 3] [Amendment: SEC Form 3 filed by new insider Framework Ventures Iv L.P.](https://www.quantisnow.com/insight/amendment-sec-form-3-filed-by-new-insider-framework-ventures-6242264)
- 2025-10-22 20:09 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-6241634)
- 2025-10-21 11:00 UTC [SEC Form 8-K] [NovaBay Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/novabay-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-6239309)
- 2025-10-21 01:40 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Kazley Michael John](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-kazley-michael-6239098)
- 2025-10-21 01:39 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Framework Ventures Iv L.P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-framework-ventures-iv-6239097)
- 2025-10-21 01:39 UTC [SEC Form 4] [SEC Form 4 filed by Large owner R01 Fund Lp](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-r01-fund-lp-6239095)
- 2025-10-21 01:38 UTC [SEC Form 3] [SEC Form 3 filed by new insider Kazley Michael John](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-kazley-michael-john-6239094)
- 2025-10-21 01:37 UTC [SEC Form 3] [SEC Form 3 filed by new insider Framework Ventures Iv L.P.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-framework-ventures-iv-6239093)
- 2025-10-21 01:37 UTC [SEC Form 3] [SEC Form 3 filed by new insider R01 Fund Lp](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-r01-fund-lp-6239092)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NBY
- Earnings history: https://www.quantisnow.com/earnings/NBY
- Dividend history: https://www.quantisnow.com/dividends/NBY
- Insider transactions: https://www.quantisnow.com/insiders/NBY
- Options chain: https://www.quantisnow.com/options/NBY
- SEC 8-K filings only: https://www.quantisnow.com/company/NBY/8-k
- RSS and alerts for NBY: https://www.quantisnow.com/docs/rss-feeds.md